Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Beta-glucan + Heyndrickxia coagulans + Inulin-type fructans (ITF) / Inulin + Lactate / Lactic Acid & Type 2 diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Clinical data

IRCT201505242709N33 - Beta-glucan + Lactic acid vs Beta-glucan + Heyndrickxia coagulans + Inulin-type fructans (ITF) / Inulin vs Beta-glucan + Heyndrickxia coagulans + Inulin-type fructans (ITF) / Inulin + Lactate / Lactic Acid & Type 2 diabetes (T2D)

This randomized, double-blinded, controlled trial revealed that daily consumption of Beta-glucan + Heyndrickxia coagulans + Inulin-type fructans (ITF) / Inulin + Lactic acid for 8 weeks had beneficial effects on HbA1c, SOD, and GSH-Px among T2D patients (1).

References

(1) Ghafouri et al. 2019 Diabetol Metab Syndr 11: 1-9

see also:
Synbiotics & Type 2 diabetes (T2D)
[Type 2 diabet…

References (Sources)

Effect of synbiotic bread containing lactic acid on glycemic indicators, biomarkers of antioxidant status and inflammation in patients with type 2 diabetes: a randomized controlled trial
Ghafouri et al. 2019 Diabetol Metab Syndr 11: 1-9

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!